Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Grabowski

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|September 10, 2014
The LIMP-2/SCARB2 binding motif on acid β-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseasesBenjamin Liou, Wendy D Haffey, Kenneth D Greis, et al.
American Journal of Hematology|March 20, 2009
Gaucher disease: resetting the clinical and scientific agendaPramod K Mistry, Neal J Weinreb, Roscoe O Brady, et al.
Annals of the New York Academy of Sciences|September 24, 2005
Saposin C: neuronal effect and CNS delivery by liposomesZhengtao Chu, Ying Sun, Chia Yi Kuan, et al.
Molecular Genetics and Metabolism|May 19, 2012
Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher diseaseManoj Kumar Pandey, Reena Rani, Wujuan Zhang, et al.
Human Gene Therapy|August 7, 2002
Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in miceHong Du, Martin Heur, David P Witte, et al.
Molecular Genetics and Metabolism|January 9, 2021
Gaucher disease: Basic and translational science needs for more complete therapy and managementGregory A Grabowski, Armand H M Antommaria, Edwin H Kolodny, et al.
Molecular Genetics and Metabolism|March 19, 2008
Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levelsYou-Hai Xu, Rachel Reboulet, Brian Quinn, et al.
Plos One|October 8, 2009
In vivo and ex vivo evaluation of L-type calcium channel blockers on acid beta-glucosidase in Gaucher disease mouse modelsYing Sun, Benjamin Liou, Brian Quinn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2003
Reduction of atherosclerotic plaques by lysosomal acid lipase supplementationHong Du, Susan Schiavi, Nick Wan, et al.
American Journal of Medical Genetics. Part A|December 12, 2002
Gaucher disease: in vivo evidence for allele dose leading to neuronopathic and nonneuronopathic phenotypesHuiquan Zhao, Laurie A Bailey, Louis J Elsas, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|September 10, 2014
The LIMP-2/SCARB2 binding motif on acid β-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseasesBenjamin Liou, Wendy D Haffey, Kenneth D Greis, et al.
American Journal of Hematology|March 20, 2009
Gaucher disease: resetting the clinical and scientific agendaPramod K Mistry, Neal J Weinreb, Roscoe O Brady, et al.
Annals of the New York Academy of Sciences|September 24, 2005
Saposin C: neuronal effect and CNS delivery by liposomesZhengtao Chu, Ying Sun, Chia Yi Kuan, et al.
Molecular Genetics and Metabolism|May 19, 2012
Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher diseaseManoj Kumar Pandey, Reena Rani, Wujuan Zhang, et al.
Human Gene Therapy|August 7, 2002
Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in miceHong Du, Martin Heur, David P Witte, et al.
Molecular Genetics and Metabolism|January 9, 2021
Gaucher disease: Basic and translational science needs for more complete therapy and managementGregory A Grabowski, Armand H M Antommaria, Edwin H Kolodny, et al.
Molecular Genetics and Metabolism|March 19, 2008
Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levelsYou-Hai Xu, Rachel Reboulet, Brian Quinn, et al.
Plos One|October 8, 2009
In vivo and ex vivo evaluation of L-type calcium channel blockers on acid beta-glucosidase in Gaucher disease mouse modelsYing Sun, Benjamin Liou, Brian Quinn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2003
Reduction of atherosclerotic plaques by lysosomal acid lipase supplementationHong Du, Susan Schiavi, Nick Wan, et al.
American Journal of Medical Genetics. Part A|December 12, 2002
Gaucher disease: in vivo evidence for allele dose leading to neuronopathic and nonneuronopathic phenotypesHuiquan Zhao, Laurie A Bailey, Louis J Elsas, et al.
Pageof 13